Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019
Background Response rates of approved systemic therapies for cutaneous T-cell lymphoma (CTCL) hover near 30%, suggesting unmet need. This study describes real-world treatment patterns and response rates of extracorporeal photopheresis (ECP) in CTCL patients.Methods A chart review was conducted in th...
Saved in:
Main Authors: | Michael Girardi (Author), Kacie Carlson (Author), Xingyue Huang (Author), Shelby L. Corman (Author), Patrick Edmundson (Author), Jordana Schmier (Author), Hrishikesh P. Kale (Author), Rutika Raina (Author), Francine Foss (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study
by: Eidi Christensen, et al.
Published: (2024) -
Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021) -
Thymoma-associated multiorgan autoimmunity treated with multimodal therapy including extracorporeal photopheresis
by: Chikoti M. Wheat, MD, et al.
Published: (2021) -
Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
by: Eleni Gavriilaki, et al.
Published: (2024) -
Outcomes of extracorporeal photopheresis in a diverse cohort of patients with cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital
by: David M. Weiner, et al.
Published: (2024)